Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Comment by lscfaon Mar 19, 2022 3:55pm
86 Views
Post# 34528630

RE:RE:RE:Derivatives exercised

RE:RE:RE:Derivatives exercised

6,779,919  $0.36 warrants exercised in Oct/Nov/Dec qtr.   



lscfa wrote:

$0.36 warrant holders exercising with expiry in 2025....
 

 

Warrants

O/S Dec 31

Ex pr

Proceeds

May19/23

670,833

.60 Per unit

(1 sh + 1/2 wrt $0.80)

Jan30/25

9,852,938

0.36

3,547,058

May19/23

5,750,000

0.80

4,600,000

 

16,273,771

 

 

 

 

 

lscfa wrote:

 

 

 

Dec31/21

 

Share

133,957,086

 

Warrants

16,273,771

Avg $0.52

Options

9,404,000

Avg $0.34

 

159,634,857

 

Conv debentures

19,565,217

$4.5 mil @$0.23

Non convert deb.

 

$2.5 mil

 

179,200,074

 

 





 

lscfa wrote:

 

Someone exercised options or warrants or convertible debt.    Did they dump shares into market?   



 

Shs o/s Dec 31

133,957,086

Shs o/s Feb 21

136,756,376

Difference

2,799,290

 



 


 




<< Previous
Bullboard Posts
Next >>